Related Experiment Video

Updated: May 15, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Molecular and cellular determinants of human iron overload cardiomyopathy

Sayli S Modak1,2, Lina Greenberg1, W Tom Stump1

  • 1Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, 63110.

Molecular Biology of the Cell
|May 13, 2026
PubMed

Insights

Iron overload cardiomyopathy (IOC) involves heart dysfunction due to excess iron. This study uses engineered heart tissue to reveal how iron impacts heart cells, leading to reduced function and arrhythmias.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Stem Cell Biology

Background:

  • Iron overload cardiomyopathy (IOC) results from elevated systemic iron, causing cardiac dysfunction and arrhythmias.
  • Understanding IOC's specific cellular and molecular mechanisms is difficult due to multi-organ system involvement.
  • Existing models struggle to fully capture the complexity of human IOC.

Purpose of the Study:

  • To develop and utilize in vitro models of human IOC to investigate cardiac dysfunction mechanisms.
  • To identify cellular and molecular pathways affected by iron overload in the heart.
  • To establish reliable models for future mechanistic and translational research in IOC.

Main Methods:

  • Human engineered heart tissues (EHTs) composed of cardiomyocytes and cardiac fibroblasts were created.
  • EHTs were subjected to iron overload conditions to mimic IOC.
  • Contractile function, relaxation, action potentials, calcium transients, and protein damage were analyzed.

Main Results:

  • Engineered heart tissues recapitulated key IOC features: reduced contractility, impaired relaxation, and arrhythmias.
  • Cardiomyocytes exhibited higher iron accumulation and reactive oxygen species production than fibroblasts.
  • Iron overload impaired calcium transient kinetics and decreased force production via oxidative damage and myosin inhibition.

Conclusions:

  • Engineered heart tissues provide a valuable in vitro model for studying human IOC.
  • Iron overload directly impacts cardiac contractility and calcium handling, contributing to arrhythmogenesis.
  • This research elucidates key mechanisms of IOC pathogenesis and offers models for further study.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...